ConductScience.org, home

Paper29100705

Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.

Yan J and 10 others. Vaccine, 2018. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine. Papers, record 29100705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29100705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.
PubMed
Journal
Vaccine
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2019-02-01
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yan JJian
2Morrow MPMatthew P
3Chu JSJaemi S
4Racine TTrina
5Reed CCCharles C
6Khan ASAmir S
7Broderick KEKate E
8Kim JJJ Joseph
9Kobinger GPGary P
10Sardesai NYNiranjan Y
11Weiner DBDavid B

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cross ProtectionMajor topic
Hemagglutinin Glycoproteins, Influenza VirusMajor topic
Influenza VaccinesMajor topic
Orthomyxoviridae InfectionsMajor topic
Vaccines, DNAMajor topic
Animals
Antibodies, Neutralizing
Antibodies, Viral
Consensus Sequence
Electroporation
Ferrets
Guinea Pigs
Hemagglutination Inhibition Tests
Influenza A Virus, H1N1 Subtype
Macaca mulatta
Mice
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
40883775Lipid nanoparticles-mRNA based on the consensus sequences of avian coronavirus S1 and N genes protect animals against multiple viral infections.J Nanobiotechnology2025https://conductscience.org/library/papers/40883775PubMed
40636108Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines.Front Immunol2025https://conductscience.org/library/papers/40636108PubMed
40398322DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo.Vaccine2025https://conductscience.org/library/papers/40398322PubMed
38193304DNA and protein-generated chimeric molecules for delivery of influenza viral epitopes in mouse and humanized NSG transfer models.Hum Vaccin Immunother2024https://conductscience.org/library/papers/38193304PubMed
36016306Progress towards the Development of a Universal Influenza Vaccine.Viruses2022https://conductscience.org/library/papers/36016306PubMed
35754779Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.Adv Nanobiomed Res2022https://conductscience.org/library/papers/35754779PubMed
33920917The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development.Viruses2021https://conductscience.org/library/papers/33920917PubMed
33466810Design and Characterization of a DNA Vaccine Based on Spike with Consensus Nucleotide Sequence against Infectious Bronchitis Virus.Vaccines (Basel)2021https://conductscience.org/library/papers/33466810PubMed
33430278The Next Generation of Influenza Vaccines: Towards a Universal Solution.Vaccines (Basel)2021https://conductscience.org/library/papers/33430278PubMed
32784907Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice.Vaccines (Basel)2020https://conductscience.org/library/papers/32784907PubMed
32328416In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure-Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity.Adv Sci (Weinh)2020https://conductscience.org/library/papers/32328416PubMed
32059697Better influenza vaccines: an industry perspective.J Biomed Sci2020https://conductscience.org/library/papers/32059697PubMed
30262507A Designer Cross-reactive DNA Immunotherapeutic Vaccine that Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy.Clin Cancer Res2018https://conductscience.org/library/papers/30262507PubMed
30062926A Synthetic Micro-Consensus DNA Vaccine Generates Comprehensive Influenza A H3N2 Immunity and Protects Mice Against Lethal Challenge by Multiple H3N2 Viruses.Hum Gene Ther2018https://conductscience.org/library/papers/30062926PubMed
30038621A Review of DNA Vaccines Against Influenza.Front Immunol2018https://conductscience.org/library/papers/30038621PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29100705

GET https://conductscience.org/api/papers/v1/29100705/authors